Giulia Guerra

Metabolic remodelling in anthracycline cardiotoxicity: mechanisms and therapeutic insights.

Anthracyclines remain a cornerstone of anticancer therapy, but their clinical use is limited by cancer therapy-related cardiac dysfunction, a major contributor to long-term cardiovascular morbidity in cancer survivors. Although traditionally attributed to oxidative stress, DNA damage and mitochondrial toxicity, emergin...